RA Capital Management - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 130 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,129,403
-33.9%
4,398,4530.0%0.59%
-31.1%
Q2 2023$45,611,958
+28.2%
4,398,4530.0%0.86%
+6.8%
Q1 2023$35,583,485
-48.6%
4,398,4530.0%0.81%
-42.6%
Q4 2022$69,275,635
+0.1%
4,398,4530.0%1.40%
-4.9%
Q3 2022$69,231,000
+12.7%
4,398,4530.0%1.48%
-9.8%
Q2 2022$61,403,000
+95.9%
4,398,453
+142.0%
1.64%
+139.3%
Q1 2022$31,339,000
-20.9%
1,817,808
+17.5%
0.68%
-83.3%
Q3 2016$39,623,000
-18.4%
1,547,152
-41.1%
4.09%
-39.2%
Q2 2016$48,534,000
-2.5%
2,627,7190.0%6.72%
+5.6%
Q1 2016$49,795,000
-27.9%
2,627,719
+2.5%
6.36%
-6.9%
Q4 2015$69,089,0002,564,5536.84%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,258,243$8,618,96513.75%
Foresite Capital Management IV, LLC 2,808,034$19,235,03310.68%
Bain Capital Life Sciences Investors, LLC 3,400,000$23,290,0002.60%
GREAT POINT PARTNERS LLC 1,691,768$11,588,6112.11%
Samsara BioCapital, LLC 696,171$4,768,7711.46%
Altium Capital Management LP 403,000$2,760,5501.44%
BVF INC/IL 7,064,736$48,393,4421.30%
Aisling Capital Management LP 434,455$2,976,0171.23%
GREAT POINT PARTNERS LLC 700,000$4,795,0000.87%
VR Adviser, LLC 1,040,754$7,129,1650.75%
View complete list of ACLARIS THERAPEUTICS INC shareholders